Kabra Drugs Complete Financial Statements
KABRADG • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Kabra Drugs (KABRADG).
Downloads include all available records across all periods.
For market performance, see the
KABRADG stock price today
.
Profitability Ratios
Net Profit Margin
-100.00%
2025 data
EBITDA Margin
-100.00%
2025 data
Return on Assets
-4.00%
2025 data
Return on Equity
-4.00%
2025 data
Balance Sheet Ratios
Debt to Equity
1.00
2025 data
Equity Ratio
100.00%
2025 data
Asset Turnover
0.04
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
+2700.0%
Year-over-Year
Net Profit Growth
+200.0%
Year-over-Year
EBITDA Growth
+300.0%
Year-over-Year
Expense Growth
+1200.0%
Year-over-Year
Assets Growth
+400.0%
Year-over-Year
Equity Growth
+2400.0%
Year-over-Year
Liabilities Growth
+400.0%
Year-over-Year
Financing Cash Flow Growth
+666.7%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 8 | 10 | 8 |
| Expenses | 26 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 7 | 9 | 8 |
| EBITDA | 2 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 1 | 0 |
| Operating Profit Margin % | 1.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -57.00% | 6.00% | 5.00% | 5.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 1 | -1 | -1 | 0 | 0 | 0 | 0 | 0 | -2 | 0 | 0 | 0 |
| Earnings Per Share (₹) | 0.20 | -0.99 | -1.68 | -0.77 | -0.42 | -0.41 | -0.14 | -0.38 | -5.37 | 0.30 | 0.06 | 0.16 |
Related Pages for Kabra Drugs
Additional stock information and data for KABRADG
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 25 | 5 | 1 | 1 | 1 | 1 | 2 | 2 | 6 | 9 | 9 |
| Current Assets | 25 | 5 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 6 | 6 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 3 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 25 | 5 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 6 | 6 |
| LIABILITIES | |||||||||||
| Total Liabilities | 25 | 5 | 1 | 1 | 1 | 1 | 2 | 2 | 6 | 9 | 9 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 25 | 1 | -1 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 3 |
| Share Capital | 24 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 1 | -6 | -5 | -5 | -5 | -4 | -4 | -4 | -2 | -2 | -2 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 |
| Financing Activities | 23 | 3 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 1 |
| Net Cash Flow | 19 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |